TABLE 1.
Patient demographics and disposition
| Characteristic | Total n = 27 (100%) |
|---|---|
| Sex | n (%) |
| Male | 14 (51.9) |
| Female | 13 (48.1) |
| Race | |
| White | 21 (77.8) |
| Black or African American | 2 (7.4) |
| Asian | 3 (11.1) |
| Other | 1 (3.7) |
| Age (years) | |
| Mean ± StD | 63.5 ± 8.39 |
| Median | 64.5 |
| Min; max | 41.8; 76.8 |
| Primary location | |
| Colon/rectum | 8 (29.6) |
| Pancreas | 4 (14.8) |
| Female reproductive tract | 3 (11.1) |
| Liver | 2 (7.4) |
| Lung | 2 (7.4) |
| Stomach | 2 (7.4) |
| Skin | 2 (7.4) |
| Head and neck | 2 (7.4) |
| Breast | 1 (3.7) |
| Parotid gland | 1 (3.7) |
| Indications | |
| Adenocarcinoma | 21 (77.8) |
| Colorectal | 8 (29.6) |
| Pancreatic | 4 (14.8) |
| Stomach | 2 (7.4) |
| Othera | 7 (25.9) |
| Epithelioid hemangioendothelioma i | 1 (3.7) |
| Hepatocellular carcinoma i | 1 (3.7) |
| Merkel cell carcinoma i | 1 (3.7) |
| Neuroendocrine i | 1 (3.7) |
| Squamous cell carcinoma ii | 2 (7.4) |
| Tonsil | 1 (3.7) |
| Ear | 1 (3.7) |
| Prior cancer treatment/s | |
| 1 | 2 (7.4) |
| 2 | 2 (7.4) |
| 3 | 7 (25.9) |
| ≥4 | 16 (59.3) |
| ECOG performance status at baseline | |
| 0 | 12 (44.4) |
| 1 | 15 (55.6) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; Max, maximum; Min, minimum; StD, standard deviation.
aOne each of breast, cervical, liver, maxillary sinus, ovarian, parotid gland, and uterine adenocarcinoma.